The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant option.
Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a rural area or had a long drive time to a specialty care facility, according to ...
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
Samay founder and CEO Dr. Maria Artunduaga says things changed pretty quickly for her startup after winning the MedTech ...
Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor ...
"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...
Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...
MedPage Today on MSN
Novel Biologic Gets Narrow Win for Preventing COPD Flare-ups
The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...
Professor of Respiratory Medicine and Allergy at the National Heart and Lung Institute, Imperial College London -- presented positive findings demonstrating the beneficial effects of Altesa ...
GoodRx reports over 5.6 million Americans live in "pulmonology deserts," lacking accessible lung care, mostly in the central ...
A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results